Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
暂无分享,去创建一个
Y. Soo | G. Yancopoulos | D. Weinreich | G. Herman | N. Braunstein | N. Sarkar | S. Ganguly | E. Forleo-Neto | L. Lipsich | J. Hamilton | G. Geba | S. Bansal | C. Brinson | D. Armas | K. Turner | I. Heirman | Yunji Kim | Wen-jun Zheng | B. Musser | J. Meyer | S. Folkerth | Meagan P. O'Brien | Flonza Isa | A. Mahmood | A. Hooper | A. Dupljak | B. Kowal | Lori Faria | S. Rasmussen | Masaru H. Oshita | Masaru Oshita